Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reactivation of occult hepatitis B virus infection following cytotoxic lymphoma therapy in an anti-HBc negative patient.

Journal of medical virology - 1 Apr 2013

Feeney Susan A, McCaughey Conall, Watt Alison P, Agnaf Moulod R El, McDougall Neil, Wend Ulrike C, Gerlich Wolfram H, Coyle Peter V

Abstract excerpt

Screening hepatitis B virus (HBV) surface antigen (HBsAg) and HBV core antibody (anti-HBc) is recommended prior to cytotoxic or immunosuppressive therapy. This case describes an anti-HBc negative, DNA positive occult HBV infection in a 71-year-old Caucasian male following rituximab-based treatment for follicular lymphoma. Pre-screening serology indicated negative HBsAg and anti-HBc. However, following sequential...

Topics

Adenine
Aged
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents
Antiviral Agents
DNA, Viral
Genotype
Hepatitis B
Hepatitis B Antibodies
Hepatitis B Surface Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Hepatitis B virus

Humans

Immunologic Factors

Lymphoma

Male

Organophosphonates

Papua New Guinea

Phylogeny

Source

Identifiers

PMID: 23359331
DOI: 10.1002/jmv.23513

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reactivation of occult hepatitis B virus infection following cytotoxic lymphoma therapy in an anti-HBc negative patient.PMID 23359331Read ↗

Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity.Semantic proximity Read ↗

Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab.Semantic proximity Read ↗

Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient.Semantic proximity Read ↗

Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab.Semantic proximity Read ↗

Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.Semantic proximity Read ↗

Fatal postlymphoma chemotherapy hepatitis B reactivation secondary to the emergence of a YMDD mutant strain with lamivudine resistance in a noncirrhotic patient.Semantic proximity Read ↗

HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy.Semantic proximity Read ↗

Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA.Semantic proximity Read ↗

Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy.Semantic proximity Read ↗

Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy.Semantic proximity Read ↗

Fulminant hepatitis B and acute hepatitis B due to intrafamilial transmission of HBV after chemotherapy for non-Hodgkin's lymphoma in an HBV carrier.Semantic proximity Read ↗

Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.